1. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction;Oelke;Eur Urol,2013
2. Gravas S (Chair), Bach T, Drake M, Gacci M, Gratzke C, Herrmann TRW, Madersbacher S, Mamoulakis C, Tikkinen KAO. Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urology; 2017.
3. Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database;Gilfrich;Prostate Cancer Prostatic Dis,2016
4. Comparative effectiveness and safety of monodrug therapies for lower urinary tract symptoms associated with benign prostatic hyperplasia: a network meta-analysis;Yuan;Medicine (Baltimore),2015
5. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update;Cornu;Eur Urol,2015